Showing results (921-930 of 1,194) with videos related to
Sort By:
Pageof 120
Pharmaceutical Statistics|May 6, 2011
Quantitative comparison of randomization designs in sequential clinical trials based on treatment balance and allocation randomnessWenle Zhao, Yanqiu Weng, Qi Wu, et al.Pharmaceutical Statistics|January 7, 2016
On the need for increased rigour and care in the conduct and interpretation of network meta-analyses in drug developmentKevin Carroll, Robert HemmingsPharmaceutical Statistics|March 19, 2016
Decision-making in early clinical drug developmentPaul Frewer, Pat Mitchell, Claire Watkins, et al.Pharmaceutical Statistics|March 19, 2016
Modelling PK/QT relationships from Phase I dose-escalation trials for drug combinations and developing quantitative risk assessments of clinically relevant QT prolongationsKaren Sinclair, Els Kinable, Kai Grosch, et al.Pharmaceutical Statistics|February 12, 2016
Distribution of the two-sample t-test statistic following blinded sample size re-estimationKaifeng LuPharmaceutical Statistics|April 11, 2016
A Bayesian hierarchical surrogate outcome model for multiple sclerosisLuca Pozzi, Heinz Schmidli, David I OhlssenPharmaceutical Statistics|June 18, 2016
Analysing adverse events by time-to-event models: the CLEOPATRA studyTanja Proctor, Martin SchumacherPharmaceutical Statistics|May 30, 2019
Detecting bliss synergy in in vivo combination studies with a tumor kinetic modelWei Zhao, Paolo Vicini, Steven Novick, et al.Pharmaceutical Statistics|April 25, 2018
Conditional estimation using prior information in 2-stage group sequential designs assuming asymptotic normality when the trial terminated earlyMasashi Shimura, Kazushi Maruo, Masahiko GoshoPharmaceutical Statistics|October 9, 2021
Practical and robust test for comparing binomial proportions in the randomized phase II settingKristopher Attwood, Soyun Park, Alan D HutsonPageof 120